Clinical trial
Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00003544 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003544 |
|---|---|
| Title | Irinotecan in Treating Patients With Metastatic Colorectal Cancer |
| Official title | A Phase II Trial of Preoperative Irinotecan (CPT-11) in Patients With High-Risk Resectable Metastatic Colorectal Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | irinotecan hydrochloride, surgical procedure |
| Start date | Jun 1, 1998 |
| Primary completion | Mar 1, 2001 |
| Completion | Mar 1, 2001 |
| First posted | Apr 27, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: